论文部分内容阅读
目的:探讨唑来膦酸联合化疗治疗非小细胞肺癌骨转移的临床疗效。方法:选取于2013年4月-2015年4月在我院接受治疗的非小细胞肺癌骨转移患者共96例,分为观察组和对照组,给予对照组TP方案治疗。给予观察组唑来膦酸联合化疗治疗。观察治疗效果。结果:观察组显效率为37.5%,明显高于对照组,组间比较差异具有统计学意义(P<0.05);观察组总有效率为95.8%,明显高于对照组,组间比较差异具有统计学意义(P<0.05)。结论:唑来膦酸联合化疗方法治疗非小细胞肺癌骨转移具有良好的临床效果,值得推广。
Objective: To investigate the clinical efficacy of zoledronic acid combined with chemotherapy in treatment of bone metastasis of non-small cell lung cancer. Methods: A total of 96 patients with bone metastasis of non-small cell lung cancer who were treated in our hospital from April 2013 to April 2015 were selected and divided into observation group and control group. TP was given to control group. Patients in the observation group were treated with zoledronic acid combined with chemotherapy. Observe the effect of treatment. Results: The markedly effective rate was 37.5% in the observation group, which was significantly higher than that in the control group (P <0.05). The total effective rate in the observation group was 95.8%, which was significantly higher than that in the control group Statistical significance (P <0.05). Conclusion: Zoledronic acid combined with chemotherapy for non-small cell lung cancer bone metastasis has a good clinical effect, it is worth promoting.